Medical Condition News

RSS

NAFC holds free educational webinar for seniors who live with incontinence

The National Association For Continence is holding a free educational webinar, Nocturia: Risk Factors for Falls & Fractures and Nighttime Fall Prevention Strategies, on Tuesday, April 20 at 8 p.m. (EST). This event will benefit seniors who live with incontinence and their caregivers.

13 Apr 2010

Drug boosting production of immune system protein worsens TB

An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.

13 Apr 2010

MS drug TYSABRI to be highlighted at 62nd AAN Annual Meeting

Biogen Idec and Elan Corporation, plc today announced 15 company-sponsored platform and poster presentations at the American Academy of Neurology's (AAN) 62nd Annual Meeting in Toronto, April 10 - 17, 2010. The AAN Annual Meeting is the world's largest gathering of neurologists.

13 Apr 2010

National organizations, medical institutions join Lung Cancer Alliance to address nation's most lethal cancer

Today, Lung Cancer Alliance announced new additions to the growing list of supporters joining LCA in its "call to action" to devise a better public health strategy to address the nation's most lethal cancer.

13 Apr 2010

Antidepressants and mood stabilizers may benefit stroke victims

A study in rodents shows the growth of new neurons, also known as neurogenesis, lessens the severity of stroke and dramatically improves function following a stroke. The research, undertaken at the Buck Institute for Age Research, suggests that drugs shown to promote neurogenesis in rodents could have benefits for human stroke victims and that those drugs-which include antidepressants and mood stabilizers such as lithium-may be suitable for study in human clinical trials.

13 Apr 2010

MS Longest Day of Golf event to raise funds for MS research

More than 40 of Michigan's best golf courses are donating greens fees on select dates in May, allowing golfers to play for free while raising funds for multiple sclerosis research, programs and services. 2010 marks the 20th anniversary of the National MS Society Michigan Chapter's "MS Longest Day of Golf" event, which takes place in both May and September.

13 Apr 2010

Tufts Medical Center researchers discover new biological pathway for advanced AMD

Researchers at Tufts Medical Center and collaborators discovered a new biological pathway for advanced age-related macular degeneration that implicates a role of the hepatic lipase gene, LIPC. This discovery will improve understanding of the disease by providing researchers another developmental pathway to explore for prevention and treatment.

13 Apr 2010

San Diego Union-Tribune examines pharma's growing interest in neglected diseases

The San Diego Union-Tribune examines the pharmaceutical industry's growing interest in developing new treatments for what are known as "neglected diseases."

13 Apr 2010

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Fisher Wallace Laboratories today announced the results of a brain stimulation study involving the Fisher Wallace Cranial Stimulator, a portable medical device that treats depression, anxiety and insomnia. The study, published in The Neuroscientist and authored by Dr. Felipe Fregni, assistant professor in neurology at Harvard Medical School, analyzes a decade's worth of research on the brain stimulation technology used by the Fisher Wallace Cranial Stimulator.

13 Apr 2010

Researchers may be one step closer to slowing the progression of Alzheimer's disease

Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.

13 Apr 2010

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

Aeolus Pharmaceuticals, Inc. announced today that a second study of its lead drug, AEOL 10150, has been initiated by the National Institutes of Health's (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasures development program as a countermeasure for radiation exposure to the gastrointestinal (GI) tract.

13 Apr 2010

Tailwind device that helps stroke survivors improve arm movement now available

The Tailwind, a new rehabilitation device that helps stroke survivors improve arm movement, even many years after their stroke, is now available on the eve of May as National Stroke Awareness Month. The exercise device empowers stroke survivors to become more independent and enables them to achieve the tasks of daily life.

13 Apr 2010

Stem cell scientists receive stimulus grants to study lung and blood disorders

Stem cell scientists at The University of Texas Health Science Center at Houston (UTHealth) were awarded stimulus grants totaling almost $2 million to research experimental treatments for blood disorders and inherited lung diseases affecting children.

13 Apr 2010

High glycemic diet in women linked to increased risk of coronary heart disease

Consuming carbohydrates with high glycemic index—an indicator of how quickly a food affects blood glucose levels—appears to be associated with the risk of coronary heart disease in women but not men, according to a report in the April 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Apr 2010

Uninsured migraine sufferers likely to get inadequate treatment: Neurology

People with no health insurance are less likely than the privately insured to receive proper treatment for their migraines, according to a study published in the April 13, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

13 Apr 2010

Stress hormones may suppress tumor growth: Study

Chronic stress triggers a chain of molecular events that protects breakaway ovarian cancer cells from destruction, a team of researchers led by scientists at The University of Texas M. D. Anderson Cancer Center reports April 12 in the early online publication of the Journal of Clinical Investigation.

13 Apr 2010

Compound that kills specific lymphoma cells discovered

An international research team co-led by the Ontario Cancer Institute has discovered a compound that kills specific lymphoma cells - a discovery that will accelerate developing targeted drugs to fight the most common form of non-Hodgkins lymphoma.

13 Apr 2010

Gene mutations may predispose individuals to schizophrenia, says new study

An international study led by Universit- de Montr-al scientists suggests that gene mutations may predispose some individuals to schizophrenia and provides new clues about the causes of this ambiguous disorder.

13 Apr 2010

New endoscopic scanning technique improves early detection of dysplasia in Barrett's esophagus

Cancer of the lower esophagus develops almost exclusively in patients with Barrett's esophagus, an otherwise benign complication of esophageal reflux that affects approximately 3 million Americans. Although the prognosis of patients diagnosed with esophageal cancer is poor, the chances of successful treatment increase significantly if the disease is detected at an early dysplastic stage.

13 Apr 2010

Decrease in manic symptoms severity influences prescribing decisions for bipolar mania

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed psychiatrists say that the decrease in severity of manic symptoms is the attribute that most influences their prescribing decisions in bipolar mania. Clinical data and the opinions of interviewed thought leaders indicate that Eli Lilly's Zyprexa (olanzapine) has advantages in this attribute over AstraZeneca/Astellas's Seroquel (quetiapine), the sales-leading agent in the bipolar disorder drug market.

13 Apr 2010

Medical Condition News

NAFC holds free educational webinar for seniors who live with incontinence

Drug boosting production of immune system protein worsens TB

MS drug TYSABRI to be highlighted at 62nd AAN Annual Meeting

National organizations, medical institutions join Lung Cancer Alliance to address nation's most lethal cancer

Antidepressants and mood stabilizers may benefit stroke victims

MS Longest Day of Golf event to raise funds for MS research

Tufts Medical Center researchers discover new biological pathway for advanced AMD

San Diego Union-Tribune examines pharma's growing interest in neglected diseases

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Researchers may be one step closer to slowing the progression of Alzheimer's disease

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

Tailwind device that helps stroke survivors improve arm movement now available

Stem cell scientists receive stimulus grants to study lung and blood disorders

High glycemic diet in women linked to increased risk of coronary heart disease

Uninsured migraine sufferers likely to get inadequate treatment: Neurology

Stress hormones may suppress tumor growth: Study

Compound that kills specific lymphoma cells discovered

Gene mutations may predispose individuals to schizophrenia, says new study

New endoscopic scanning technique improves early detection of dysplasia in Barrett's esophagus

Decrease in manic symptoms severity influences prescribing decisions for bipolar mania

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News